WGRX Estados financieros: Análisis de Wellgistics Health Inc AI



Finanzas

WGRX Financiero

Wellgistics Health Inc

$2.98

-2.93%

$-0.08

Al cierre: Jul 02, 16:00:00 GMT-4

$2.88

-3.35%

$-0.1

Mercado Posterior: Jul 02, 20:00:00 GMT-4

Visión general Pronóstico Ganando Dividendos Finanzas

Estadísticas clave

Cierre Anterior

$3.07

Precio de apertura

$3.08

Rango del día

$2.88 - $3.08

Rango de 52 semanas

$2.88 - $97.5

Volumen

9.2K

Volumen promedio

545.2K

Rendimiento de dividendos

EPS (TTM)

-41.30

Cap. de mercado

$7.2M

¿Qué es WGRX?

Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. The company is headquartered in Tampa, Florida. The company went IPO on 2025-02-21. The company focuses on specialty medications and a community-based model offering home delivery services to patients. The company is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Ingresos	14	1	1	3	7	10
Crecimiento de los Ingresos (YoY)	-50%	-90%	-92%	-40%	--	--
Costo de los ingresos	20	1	9	2	7	10
Utilidad bruta	-6	0	-7	0	0	0
Venta, General y Administración	46	5	4	30	5	31
Investigación y Desarrollo	--	--	--	--	--	--
Gastos de Operación	48	6	4	31	6	32
Otras Ingresos (Gastos) No Operativos	0	0	0	0	0	0
Ingreso antes de impuestos	-76	-7	-27	-34	-6	-32
Gasto por Impuesto a la Renta	0	0	0	0	0	0
Ingreso Neto	-76	-7	-27	-34	-6	-32
Crecimiento de la Utilidad Neta	95%	-78%	575%	3,300%	--	--
Acciones en Circulación (Diluidas)	2.09	2.09	1.93	1.48	61.77	51.91
Cambio de Acciones (YoY)	-96%	-96%	-94%	-97%	19%	--
EPS (Diluido)	-36.6	-3.7	-14.42	-23.06	-0.1	-0.62
Crecimiento de EPS	4,780%	492%	10,942%	64,161%	873%	--
Flujo de efectivo libre	-13	-3	-6	-1	-2	-1
Flujo de efectivo libre por acción	--	--	--	--	--	--
Margen bruto	-42.85%	0%	-700%	0%	0%	0%
Margen de operación	-392.85%	-600%	-1,200%	-1,033.33%	-71.42%	-310%
Margen de beneficio	-542.85%	-700%	-2,700%	-1,133.33%	-85.71%	-320%
Margen de flujo de caja libre	-92.85%	-300%	-600%	-33.33%	-28.57%	-10%
EBITDA	-53	-6	-12	-31	-5	-31
Margen de EBITDA	-378.57%	-600%	-1,200%	-1,033.33%	-71.42%	-310%
D&A para EBITDA	2	0	0	0	0	0
EBIT	-55	-6	-12	-31	-5	-31
Margen de EBIT	-392.85%	-600%	-1,200%	-1,033.33%	-71.42%	-310%
Tasa de Impuesto Efectiva	0%	0%	0%	0%	0%	0%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Ingresos

Crecimiento de los Ingresos (YoY)

-50%

-90%

-92%

-40%

Costo de los ingresos

Utilidad bruta

-6

-7

Venta, General y Administración

Investigación y Desarrollo

Gastos de Operación

Otras Ingresos (Gastos) No Operativos

Ingreso antes de impuestos

-76

-7

-27

-34

-6

-32

Gasto por Impuesto a la Renta

Ingreso Neto

-76

-7

-27

-34

-6

-32

Crecimiento de la Utilidad Neta

95%

-78%

575%

3,300%

Acciones en Circulación (Diluidas)

2.09

1.93

1.48

61.77

51.91

Cambio de Acciones (YoY)

-96%

-94%

-97%

19%

EPS (Diluido)

-36.6

-3.7

-14.42

-23.06

-0.1

-0.62

Crecimiento de EPS

4,780%

492%

10,942%

64,161%

873%

Flujo de efectivo libre

-13

-3

-6

-1

-2

-1

Flujo de efectivo libre por acción

Margen bruto

-42.85%

-700%

Margen de operación

-392.85%

-600%

-1,200%

-1,033.33%

-71.42%

-310%

Margen de beneficio

-542.85%

-700%

-2,700%

-1,133.33%

-85.71%

-320%

Margen de flujo de caja libre

-92.85%

-300%

-600%

-33.33%

-28.57%

-10%

EBITDA

-53

-6

-12

-31

-5

-31

Margen de EBITDA

-378.57%

-600%

-1,200%

-1,033.33%

-71.42%

-310%

D&A para EBITDA

EBIT

-55

-6

-12

-31

-5

-31

Margen de EBIT

-392.85%

-600%

-1,200%

-1,033.33%

-71.42%

-310%

Tasa de Impuesto Efectiva

Follow-Up Questions

What are Wellgistics Health Inc's key financial statements?



According to the latest financial statement (Form-10K), Wellgistics Health Inc has a total asset of $0, Net pérdida of $0

What are the key financial ratios for WGRX?



Wellgistics Health Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Wellgistics Health Inc's revenue broken down by segment or geography?



Actualmente no hay datos disponibles para Wellgistics Health Inc.

Is Wellgistics Health Inc profitable?



no, according to the latest financial statements, Wellgistics Health Inc has a net pérdida of $0

Does Wellgistics Health Inc have any liabilities?



no, Wellgistics Health Inc has liability of 0

How many outstanding shares for Wellgistics Health Inc?



Wellgistics Health Inc has a total outstanding shares of 0

Wellgistics Health Inc (WGRX) Financiero

Gráfico del Precio de Acciones WGRX

Estadísticas clave

Cierre Anterior

Precio de apertura

Rango del día

Rango de 52 semanas

Volumen

Volumen promedio

Rendimiento de dividendos

EPS (TTM)

Cap. de mercado

¿Qué es WGRX?

Wellgistics Health Inc (WGRX) Financiero

Gráfico del Precio de Acciones WGRX

Estadísticas clave

Cierre Anterior

Precio de apertura

Rango del día

Rango de 52 semanas

Volumen

Volumen promedio

Rendimiento de dividendos

EPS (TTM)

Cap. de mercado

¿Qué es WGRX?

WGRX Ingreso

Follow-Up Questions

What are Wellgistics Health Inc's key financial statements?

What are the key financial ratios for WGRX?

How is Wellgistics Health Inc's revenue broken down by segment or geography?

Is Wellgistics Health Inc profitable?

Does Wellgistics Health Inc have any liabilities?

How many outstanding shares for Wellgistics Health Inc?